- Epinephrine
- Steroids
- Antihistamines
- Beta-antagonists
- Others
Anaphylaxis Treatment Market size was valued at USD 3,104.4 million in 2022 and is expected to grow at an 8.9% CAGR from 2023 to 2029. Anaphylaxis is a serious allergic condition that may cause even death of the patients. Throat swelling, vomiting, shortness of breath, itchy rash, and low blood screening pressure are some symptoms of anaphylaxis. Insect bites, unwanted food consumption, and medications are some of the causes of anaphylaxis. The increasing number of allergic patients across the globe is expected to drive the growth of the anaphylaxis treatment market. For instance, about 150 million Europeans are affected by chronic allergies each year and according to the National Institute of Healthcare Excellence, more than 20 people die in the UK owing to improper treatment of anaphylaxis. In addition, increasing research and development of anti-anaphylaxis drug quality and increasing anaphylaxis treatment market demand for self-administration treatment are anticipated to boost the growth of the anaphylaxis treatment market. Furthermore, increasing awareness about the treatment of anaphylaxis, increasing geriatric population, and rising overuse of medicines in rural areas is anticipated to have a positive impact on the growth of the anaphylaxis treatment market over the forecast period. However, side effects caused by the administration of epinephrine and steroids, and lack of knowledge in developing countries is expected to hinder the growth of anaphylaxis treatment market. Moreover, increasing investments in many countries, and increasing government support in lowering the treatment cost and increasing product approvals are anticipated to provide opportunities to the manufacturers and market players in the growth of anaphylaxis treatment market over the forecast period.
Anaphylaxis Treatment Market Key Developments:
- In March 2022, Aquestive Therapeutics Inc. announced their USFDA approval of AQST-109, the first orally delivered epinephrine-based drug for the emergency treatment of allergic reactions.
Global Anaphylaxis Treatment Market Summary
Study Period
2023-29
Base Year
2022
CAGR
8.9%
Largest Market
North America
Fastest Growing Market
North America
Anaphylaxis Treatment Market Dynamics
The anaphylaxis treatment market is expected to grow over the forecasted period owing to the increasing incidence of allergies and anaphylaxis. For instance, according to the Centre for Disease Control and Prevention, the prevalence of food allergies in children under 18 years has risen by 50% in the last two decades in the US. Thus, this increasing incidence of anaphylaxis is expected to increase the demand for effective and convenient anaphylaxis treatment. In addition, increasing awareness of treatment and increasing research and development has resulted in innovation of new pipeline drugs. Thus, these factors are expected to drive the growth of the anaphylaxis treatment market over the forecast period.
North-America Got Significant Share
Anaphylaxis Treatment Market Regional Analysis
The anaphylaxis treatment market is segmented based on regions into North America, Asia-pacific, Europe, Latin America, and the Middle East and Africa. The North America anaphylaxis treatment market is likely to hold a significant revenue share, and in the forecasted years, it is predicted to increase rapidly due to the increasing incidence of allergies and anaphylaxis in this region. In addition, increasing awareness of allergy testing and fatalities caused by various severe allergies is expected to drive the anaphylaxis treatment market in this region. Europe region is expected to have highest CAGR in the forecast years owing to the rapid adoption of novel products in anaphylaxis treatment in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The anaphylaxis treatment market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Anaphylaxis Treatment Market Segmentation
By Drug Class
By Route of Administration
- Oral
- Parenteral
- Others
By Application
- Food Allergy
- Pollen Allergy
- Dust Mites Allergy
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacie
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The anaphylaxis treatment market size was valued at USD 3,104.4 million in 2022
The anaphylaxis treatment market key players are: Pfizer Inc. Mylan N.V GlaxoSmithKline Plc Amneal Pharmaceuticals Merck & Co Inc Teva Pharmaceutical Industries ltd. Adamis Pharmaceutical Corporation Abbott Laboratories Sandoz Inc. Aquestive Therapeutics Inc. Amphastar Pharmaceuticals Inc.
The anaphylaxis treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Anaphylaxis Treatment Market Introduction |
| 2.1.Global Anaphylaxis Treatment Market - Taxonomy |
| 2.2.Global Anaphylaxis Treatment Market - Definitions |
| 2.2.1.Drug Class |
| 2.2.2.Route of Administration |
| 2.2.3.Application |
| 2.2.4. Distribution Channel |
| 2.2.5.Region |
| 3.Global Anaphylaxis Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Anaphylaxis Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Anaphylaxis Treatment Market By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Epinephrine |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Steroids |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Antihistamines |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Beta-antagonists |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Anaphylaxis Treatment Market By Route of Administration, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Low Tension Glaucoma |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Anaphylaxis Treatment Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Food Allergy |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pollen Allergy |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Dust Mites Allergy |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Anaphylaxis Treatment Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacie |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Anaphylaxis Treatment Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Epinephrine |
| 10.1.2.Steroids |
| 10.1.3.Antihistamines |
| 10.1.4.Beta-antagonists |
| 10.1.5.Others |
| 10.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.2.3.Others |
| 10.2.4.Low Tension Glaucoma |
| 10.2.5.Others |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Food Allergy |
| 10.3.2.Pollen Allergy |
| 10.3.3.Dust Mites Allergy |
| 10.3.4.Others |
| 10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacie |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Epinephrine |
| 11.1.2.Steroids |
| 11.1.3.Antihistamines |
| 11.1.4.Beta-antagonists |
| 11.1.5.Others |
| 11.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.2.3.Others |
| 11.2.4.Low Tension Glaucoma |
| 11.2.5.Others |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Food Allergy |
| 11.3.2.Pollen Allergy |
| 11.3.3.Dust Mites Allergy |
| 11.3.4.Others |
| 11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacie |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Epinephrine |
| 12.1.2.Steroids |
| 12.1.3.Antihistamines |
| 12.1.4.Beta-antagonists |
| 12.1.5.Others |
| 12.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.2.3.Others |
| 12.2.4.Low Tension Glaucoma |
| 12.2.5.Others |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Food Allergy |
| 12.3.2.Pollen Allergy |
| 12.3.3.Dust Mites Allergy |
| 12.3.4.Others |
| 12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacie |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Epinephrine |
| 13.1.2.Steroids |
| 13.1.3.Antihistamines |
| 13.1.4.Beta-antagonists |
| 13.1.5.Others |
| 13.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.2.3.Others |
| 13.2.4.Low Tension Glaucoma |
| 13.2.5.Others |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Food Allergy |
| 13.3.2.Pollen Allergy |
| 13.3.3.Dust Mites Allergy |
| 13.3.4.Others |
| 13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacie |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Anaphylaxis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Epinephrine |
| 14.1.2.Steroids |
| 14.1.3.Antihistamines |
| 14.1.4.Beta-antagonists |
| 14.1.5.Others |
| 14.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Oral |
| 14.2.2.Parenteral |
| 14.2.3.Others |
| 14.2.4.Low Tension Glaucoma |
| 14.2.5.Others |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Food Allergy |
| 14.3.2.Pollen Allergy |
| 14.3.3.Dust Mites Allergy |
| 14.3.4.Others |
| 14.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospital Pharmacies |
| 14.4.2.Retail Pharmacies |
| 14.4.3.Online Pharmacie |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Pfizer Inc. |
| 15.2.2.Mylan N.V |
| 15.2.3.GlaxoSmithKline Plc |
| 15.2.4.Amneal Pharmaceuticals |
| 15.2.5.Merck & Co Inc |
| 15.2.6.Teva Pharmaceutical Industries ltd. |
| 15.2.7.Adamis Pharmaceutical Corporation |
| 15.2.8.Abbott Laboratories |
| 15.2.9.Sandoz Inc. |
| 15.2.10.Aquestive Therapeutics Inc. |
| 15.2.11.Amphastar Pharmaceuticals Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Pfizer Inc.
- Mylan N.V
- GlaxoSmithKline Plc
- Amneal Pharmaceuticals
- Merck & Co Inc
- Teva Pharmaceutical Industries ltd.
- Adamis Pharmaceutical Corporation
- Abbott Laboratories
- Sandoz Inc.
- Aquestive Therapeutics Inc.
- Amphastar Pharmaceuticals Inc.